Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04030312 · ClinicalTrials.gov registry record · NA

Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant

A NA study of Neonatal Hypoglycemia, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT04030312 is a NA study of Neonatal Hypoglycemia that has completed, run by University of Nebraska. The registered enrollment target is 18 participants, below the 139-participant average among 5 other Neonatal Hypoglycemia trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04030312, a NA study of Neonatal Hypoglycemia, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare if newborn infant hypoglycemia can be improved with bottle supplementation of commercially-sterilized donor human milk compared to standard infant formula. Hypothesis is that supplementation with commercially-sterilized donor human milk will improve hypoglycemia and limit formula use in exclusively breastfed infants.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Bottle Supplementation--Commercially-Sterilized Donor Human Milk
  • DIETARY_SUPPLEMENT Bottle Supplementation--Standard Infant Formula

Study Locations (1)

Nebraska

  • University of Nebraska Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2020-05-01
Est. Completion 2023-04-10
Phase NA

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT04030312

The ClinicalTrials.gov registry entry for NCT04030312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 139-participant average among 5 other Neonatal Hypoglycemia trials with a reported enrollment target (87% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Neonatal Hypoglycemia appearing as the primary indexed condition, and to 2 interventions - of which Bottle Supplementation--Commercially-Sterilized Donor Human Milk is the first listed.

NCT04030312 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT04030312 about?

NCT04030312 is a clinical study titled "Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant". The purpose of this study is to compare if newborn infant hypoglycemia can be improved with bottle supplementation of commercially-sterilized donor human milk compared to standard infant formula. Hypothesis is that supplementation with commercially-sterilized donor human milk will improve hypoglycem...

What is the current status of trial NCT04030312?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2020-05-01. Estimated completion is 2023-04-10.

What conditions does trial NCT04030312 study?

This clinical trial studies the following conditions: Neonatal Hypoglycemia.

What interventions are being tested in trial NCT04030312?

The interventions under investigation include: Bottle Supplementation--Commercially-Sterilized Donor Human Milk (DIETARY_SUPPLEMENT), Bottle Supplementation--Standard Infant Formula (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04030312?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04030312 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neonatal Hypoglycemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.